Ohtuvayre 3mg/2.5ml Inh Suspension
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. You will inhale this medication through your mouth using a special machine called a nebulizer. Your doctor will teach you how to use the nebulizer properly. Be sure to use only the type of nebulizer recommended by your doctor. If you're unsure, consult with your doctor.
Important Administration Instructions
Do not swallow this medication.
Do not mix this medication with any other liquid medications.
Do not add other medications to the nebulizer.
Do not open the ampule until you are ready to take a dose.
After opening, discard any unused portion of the ampule.
Shake the solution well before use. The solution should appear cloudy and yellow to pale yellow. Do not use if the solution changes color or appears cloudy, leaking, or contains particles.
Nebulizer Care and Maintenance
Follow the instructions for cleaning the nebulizer carefully. Each ampule is for single use only. After using an ampule, dispose of it in the trash, out of the reach of children, as it may pose a choking hazard.
Taking Multiple Inhaled Medications
If you are taking more than one inhaled medication, consult with your doctor to determine the best order for taking your medications.
Continuing Treatment
Continue using this medication as directed by your doctor or healthcare provider, even if you feel well.
Storage and Disposal
Store this medication at room temperature, away from heat and sunlight. Do not freeze. Keep unused containers in their foil pouches until use.
Missed Dose
If you miss a dose, take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at the same time or extra doses.
Lifestyle & Tips
- Continue to avoid smoking and exposure to secondhand smoke, as this is crucial for managing COPD.
- Follow your healthcare provider's instructions for using your nebulizer correctly.
- Do not stop using Ohtuvayre without talking to your doctor, even if you feel better.
- Maintain regular physical activity as tolerated and recommended by your doctor.
- Get recommended vaccinations (e.g., flu, pneumonia) to prevent respiratory infections.
- Attend all scheduled follow-up appointments with your healthcare provider.
Available Forms & Alternatives
Available Strengths:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention right away:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood pressure, including:
+ Severe headache
+ Dizziness
+ Fainting
+ Changes in eyesight
New or worsening behavioral or mood changes, such as:
+ Depression
+ Thoughts of suicide
Trouble sleeping
Bladder irritation
Pain while urinating
Frequent urination
Respiratory Emergency
This medication can cause severe breathing problems, which may be life-threatening, shortly after taking a dose. If you experience trouble breathing, worsening breathing, wheezing, or coughing after using this medication, use a rescue inhaler and seek medical help immediately.
Other Possible Side Effects
Like all medications, this drug can cause side effects, although many people may not experience any or may only have mild side effects. If you are bothered by any of the following side effects or if they do not go away, contact your doctor or seek medical attention:
Back pain
* Diarrhea
Reporting Side Effects
This list is not exhaustive, and you may experience other side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Sudden worsening of breathing problems (dyspnea)
- Increased cough or changes in sputum color/amount
- Signs of infection (fever, chills)
- Severe or persistent headache
- Unusual or severe nausea or diarrhea
- Any new or worsening chest pain
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, any of its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
All medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This information will help your doctor and pharmacist identify potential interactions between this medication and other substances you are taking.
* Any existing health problems you have, as this medication may interact with certain conditions or exacerbate underlying health issues.
To ensure your safety, it is crucial to verify that it is safe to take this medication with all your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
Precautions & Cautions
Overdose Information
Overdose Symptoms:
- Exaggerated adverse effects (e.g., severe headache, nausea, vomiting, diarrhea)
- Cardiovascular effects (e.g., tachycardia, palpitations, hypotension)
- Central nervous system effects (e.g., dizziness, tremor)
What to Do:
Seek immediate medical attention or call a poison control center (1-800-222-1222). Treatment is supportive and symptomatic.
Drug Interactions
Moderate Interactions
- Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): May increase ensifentrine exposure. Use with caution.
- Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): May decrease ensifentrine exposure. Use with caution.
Monitoring
Baseline Monitoring
Rationale: To establish baseline lung function and assess disease severity.
Timing: Prior to initiation of therapy
Rationale: To establish baseline and monitor therapeutic response.
Timing: Prior to initiation of therapy
Routine Monitoring
Frequency: Periodically, as clinically indicated (e.g., every 3-6 months)
Target: Improvement from baseline
Action Threshold: Lack of improvement or worsening symptoms may indicate need for re-evaluation of treatment plan
Frequency: Regularly, especially during initial weeks of therapy and with dose changes
Target: Absence or tolerability of side effects
Action Threshold: Persistent or severe adverse effects warrant dose adjustment or discontinuation
Frequency: At each follow-up visit
Target: Reduction in frequency and severity of symptoms
Action Threshold: Worsening symptoms or increased exacerbations require reassessment
Symptom Monitoring
- Worsening dyspnea
- Increased cough or sputum production
- Chest tightness
- Signs of respiratory infection
- Headache
- Nausea
- Diarrhea
Special Patient Groups
Pregnancy
There are no adequate and well-controlled studies of Ohtuvayre in pregnant women. Animal studies have not shown evidence of developmental toxicity. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Trimester-Specific Risks:
Lactation
It is not known whether ensifentrine is excreted in human milk. Consider the developmental and health benefits of breastfeeding along with the motherβs clinical need for Ohtuvayre and any potential adverse effects on the breastfed infant from Ohtuvayre or from the underlying maternal condition.
Pediatric Use
Safety and effectiveness in pediatric patients (under 18 years of age) have not been established for COPD. Ohtuvayre is not indicated for use in pediatric patients.
Geriatric Use
No overall differences in safety or effectiveness were observed between elderly and younger adult patients. No dose adjustment is required based on age.
Clinical Information
Clinical Pearls
- Ohtuvayre is a novel, first-in-class dual PDE3/PDE4 inhibitor, offering both bronchodilator and anti-inflammatory effects in a single inhaled medication.
- It is administered via nebulizer, which may be beneficial for patients who struggle with inhaler technique or have severe airflow limitation.
- Unlike inhaled corticosteroids, ensifentrine is a non-steroidal anti-inflammatory agent, potentially offering an alternative for patients who cannot tolerate or do not respond well to steroids.
- It is approved for maintenance treatment of COPD and should not be used for acute bronchospasm.
- Patients should be instructed on proper nebulizer use and maintenance.
Alternative Therapies
- Long-acting beta-agonists (LABAs) e.g., salmeterol, formoterol, indacaterol, olodaterol
- Long-acting muscarinic antagonists (LAMAs) e.g., tiotropium, aclidinium, glycopyrronium, umeclidinium
- Inhaled corticosteroids (ICS) e.g., fluticasone, budesonide, mometasone (often in combination with LABA)
- Combination LABA/LAMA inhalers
- Combination ICS/LABA inhalers
- Oral phosphodiesterase-4 inhibitors (e.g., roflumilast)
- Oral corticosteroids (for exacerbations)
- Theophylline (less common due to narrow therapeutic index)